Skip to main content
SpringerLink
Log in

Bipolare Erkrankungen — sind moderne Neuroleptika eine neue Option?

  • Conference paper
Book cover 6. Bad Homburger ZNS-Gespräche

  • 13 Accesses

Zusammenfassung

Der Heterogenität bipolarer Störungen Rechnung tragend, wurden in den letzten Jahren verschiedene Alternativen zur bisherigen Standardtherapie Lithium entwickelt. Neben Antiepileptika kommen zunehmend auch moderne Neuroleptika zum Einsatz, von denen insbesondere die Patienten profitieren, bei denen traditionell verwendete Stimmungs- stabilisierer nicht den gewünschten Therapieerfolg brachten.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literaturs

  1. Angst J, Marneros A (2001) Bipolarity from ancient to modern times: conception, birth and rebirth. J Affect Disord 67: 3–19

    Article  CAS  PubMed  Google Scholar 

  2. Strakowski SM et al. (1998) Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J Clin Psychiatry 59(9): 465–471

    Article  CAS  PubMed  Google Scholar 

  3. Goodwin FK, Jamison KR (1990) Manic-depressive illness. New York, Oxford University Press

    Google Scholar 

  4. Frye MA et al. (2000) The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 61: 9–15

    Article  CAS  PubMed  Google Scholar 

  5. Tohen M et al. (1999) Olanzapine in the treatment of mania: a double-blind, placebo-controlled four week study. Eur Neuropsychopharmacol (9 Suppl) 5: 247

    Google Scholar 

  6. Tohen M et al. (2000) Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 57: 841–849

    Article  CAS  PubMed  Google Scholar 

  7. Tohen M et al. (2002) Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 59: 62–69

    Article  CAS  PubMed  Google Scholar 

  8. Sanger TM et al. (2001) Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J Clin Psychiatry 62: 273–281

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. München, Deutschland

    Heinz Grunze

Authors
  1. Heinz Grunze
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik und Poliklinik, Ludwig-Maximilians-Universität, Nußbaumstraße 7, 80336, München, Deutschland

    Hanns Hippius

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Grunze, H. (2003). Bipolare Erkrankungen — sind moderne Neuroleptika eine neue Option?. In: Hippius, H. (eds) 6. Bad Homburger ZNS-Gespräche. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05556-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05556-4_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00139-3

  • Online ISBN: 978-3-662-05556-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation